China issued technical guidelines for clinical trials of immune cell therapy products

Insights Pharma 02

China issued technical guidelines for clinical trials of immune cell therapy products, including CAR-T, TCR-T, TIL, CIK, etc.

China issued technical guidelines for clinical trials of immune cell therapy products. These guidelines will affect common immune cell therapy products including CAR-T, TCR-T, TIL, CIK, etc.

As a new type of treatment, cell therapy has breakthrough significance in the treatment of cancer and other diseases. Stem cells, immune cells, and other somatic cell therapy technologies have been proven to achieve curative effects that chemotherapeutics and targeted drugs cannot achieve.

 

Contact RegASK for more details Read more

Ready to get started?

Request a demo